MHz OCT: Why faster is better

Article

OCT has come a long way since its introduction but there is still room for improvement.

OCT has come a long way since its introduction but there is still room for improvement. Dr Aljoscha Neubauer discussed the history of OCT and how he believes it’s future lies in scanning speed in May's print issue of Ophthalmology Times Europe.

According to Dr Neubauer, despite the leaps forward in OCT technology there are still several shortcomings that need to be addressed.

Speed is still an issue. Even though there was an increase between time domain and spectral domain technologies, the latter capable of scan speeds of 20,000 to 50,000 A-scans per second, the current technology still does not allow for dense OCT cubes of the posterior pole to be obtained without lengthy examinations and/or eye tracking. “Moreover, there is still the need to predefine scan protocols for each individual patient," said Dr Neubauer.

To overcome this many surgeons simply consider the posterior pole imaging to be separated into retina and glaucoma sections. However, Dr Neubauer stresses that these predefined areas seem to be technically mandated rather than being based on disease and anatomy.

A further issue to consider in Dr Neubauer's opinion is the quality of the fundus images, which can be unsatisfactory if obtained with infrared alone.

Looking to the future, Dr Neubauer believes that ophthalmic OCT technology may move away from spectral domain based systems towards wavelength swept source ones. In particular, he describes Fourier domain locking (FDML) lasers.

An advantage of this technology is the scan speed, which is in the megahertz range. This speed enables imaging to be performed of the complete posterior pole within one 3D dataset and with dense isotropic sampling in the X-Y plane.

This ability means that the need to predefine a region of interest before the scan will be eliminated. "This also enables new analysis protocols to be defined and may provide advantages in segmenting layers," said Dr Neubauer. Additionally, for patient follow up the corresponding 3D volumes can be easily matched rather than needing eye-tracking as with current technology.

In summary, Dr Neubauer stated, "Generating one high-density 3D dataset covering the complete posterior pole including optic disc and macula region, all in less than one second, appears compelling."

If you would like to learn more about MHz OCT, see Dr Neubauer's full article in the May print issue of OTEurope.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.